AstraZeneca
AZN
#46
Rank
S$363.59 B
Marketcap
S$117.27
Share price
1.34%
Change (1 day)
34.13%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): S$3.98

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is S$3.91. In 2024 the company made an earnings per share (EPS) of S$2.92 an increase over its 2023 EPS that were of S$2.47.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$3.9836.24%
2024S$2.9218.23%
2023S$2.4781.13%
2022S$1.37631.03%
2021S$0.19-88.11%
2020S$1.57136.89%
2019S$0.66-39.41%
2018S$1.09-28.27%
2017S$1.53-14.37%
2016S$1.7824.11%
2015S$1.44127.55%
2014S$0.63-51.96%
2013S$1.31-58.95%
2012S$3.20-32.2%
2011S$4.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
S$3.83-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.22-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.78 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$4.63 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
S$4.77 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
S$26.43 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.45 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.38 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.16 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.48 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland